The 2010 Science School for Physicians will be hosted by the Washington
University in St. Louis School of Medicine and will take place September 12-17, 2010. Deadline for applications is May 1st, 2010.
Learning Objectives:
1) To gain a basic understanding of research methods (basic/laboratory and clinical/translational) used in diabetes-related research;
2) To understand how these methodologies can be utilized to address specific research hypotheses and answer specific research questions;
3) To gain an understanding of how to interpret research data and critically evaluate research papers and presentations;
4) To understand the strengths and weaknesses of different research designs in hypothesis testing;
5) To understand how to differentiate different types of diabetes (type 1, type 2, monogenic/MODY) in youth.
Convener: Dr Neil White, University of Washington.
Contact: white_n@kids.wustl.edu
Welcome to ISPAD
What is ISPAD ?
Globally, diabetes is a disease in evolution affecting more and more children and adolescents. ISPAD is a professional organization whose aims are to promote clinical and basic science, research, education and advocacy in childhood and adolescent diabetes. The strength of ISPAD lies in the scientific and clinical expertise in childhood and adolescent diabetes of its members. ISPAD is the only international society focusing specifically on all types of childhood diabetes. All forms of diabetes treatment in childhood should be based upon scientific evidence or clinical consensus. Parents are urged to contact their doctor regarding any type of treatment to take part of the evidence for it. Who may become an ISPAD member ? Full Members of ISPAD are medical health professionals (pediatricians, internists and other disciplines), non-medical health professionals (diabetes nurses, dieticians, psychologists, social workers and other members of diabetes teams) and scientists committed to clinical care, education, research or advocacy relevant to children and adolescents with all forms of diabetes mellitus. Pediatric Diabetes is our official journal and included in the membership fee is a subscription and free web-access. The initial two years of membership is free for applicants from non-high income countries according to the World Bank list. For members, click here to access Pediatric Diabetes. If you have been a member, and want to renew you membership, please write an e-mail to our secretariat at secretariat@ispad.org What does ISPAD do? Our activities include: The Annual Scientific Meeting is held yearly in different international locations. ISPAD publishes Clinical Practice Consensus Guidelines for the management of diabetes in children and adolescents. These are published in Pediatric Diabetes and the 2009 Guidelines are freely accessible through our website by clicking here. The yearly ISPAD Science School offers research training in the field of diabetes for young doctors. ISPAD Science School for Health Professionals is also held each year and is organized for nurses, dietitians, psychologists and other allied health professionals. The participation in the Science Schools is for members only, and includes free travel, accommodation and meals. The ISPAD Rare Diabetes Collection provides clinical details on rare types of diabetes, as well as serving as a repository of stored DNA for research. Other activities include postgraduate courses, particularly in less developed countries, scientific symposia, workshops and training programs, facilitation of collaborative studies, individual training programs, assistance with other organizations and societies in promoting education and research on childhood and adolescent diabetes mellitus as well as raising public awareness about diabetes mellitus. Forgot your password? Please contact our secretariat at secretariat@ispad.org to get your login details. BECOME A MEMBER
Want to join ISPAD?
Click here to become a member. |
Upcoming Events2010 ISPAD Science School for Physicians
12. Sep 2010
0:00 -
17. Sep 2010
0:00
, St. Louis, USA
2010 Science School for Health Professionals
24. Oct 2010
0:00 -
26. Oct 2010
0:00
, Buenos Aires, Argentina
The Seventh ISPAD Science School for Health Professionals will be held in Buenos Aires, Argentina, 24th October – 26th October 2010, immediately prior to the 36th Annual Scientific Meeting of ISPAD. The 3 day Science School is a foundation course in research methodology designed for allied health professionals (dietitians, nurses, psychologists, and social workers) who have or wish to develop a research interest in diabetes in children and adolescents.
Lead Conveners Professor Alan Delamater, Psychologist, adelamater@med.miami.edu Carmel Smart, Dietitian carmel.smart@hnehealth.nsw.gov.au Closing date for applications: 14th March 2010 ISPAD 36th Annual Meeting 2010
27. Oct 2010
0:00 -
30. Oct 2010
12:00
, Buenos Aires, Argentina
October 2010, right in the middle of spring in the southern hemisphere, celebrating the 200th birth anniversary of its Nation and its first national government, the city of Buenos Aires is ready to receive all the participants to the 36th ISPAD Annual Meeting, the first ISPAD Meeting in Latin America. Argentina and Latin America are very proud that Buenos Aires has been chosen as the venue for this Meeting.
The Scientific Programme will provide great opportunities to learn and discuss new information concerning diagnostic and therapeutic developments as well as cutting edge data in several fields of diabetes research and care: new and exciting advances in the fields of prevention and management of diabetes and all its interrelated factors. Simultaneous English – Spanish translation will be provided at this multidisciplinary meeting for pediatricians, nurses, nutritionists, psychologists and other members of the health group. Dr. Olga Ramos, MD Conference President |
Latest NewsISPAD Clinical Practice Consensus Guidelines 2009 Compendium
The 2009 ISPAD Clinical Practice Consensus Guidelines have now been published as a compendium in a Supplement to Pediatric Diabetes. We thank the international writing teams for their efforts in writing and updating these guidelines. The editors have been: Ragnar Hanas, Kim Donaghue, Georgeanna Klingensmith and Peter GF Swift.
Click here to find the files. ISPAD Prizes 2009
ISPAD´s prizes for 2009 were presented at the annual meeting in Ljubljana, Slovenia. The ISPAD Prize for Achievement is the Society’s highest honour. It is awarded to any individual who has made outstanding contributions in the areas of SCIENCE, EDUCATION or ADVOCACY which have had a major impact on childhood and adolescent diabetes. The ISPAD Prize for Achievement (sponsored by Eli Lilly) may be awarded to members or non-members of ISPAD.
The 2009 Prize for Achievement was awarded to Martin Silink, Sydney, Australia. The Lestradet Prize for Education and Advocacy (sponsored by Lifescan) was awarded to Viorel Serban, Timisoara, Romania and the Young Investigator Award (sponsored by Medtronic) was awarded to Jamil Malik, Amsterdam, The Netherlands. Alan Drash Memorial
Allan Drash, one of the leaders of ISPAD (formerly ISGD), has recently passed away. He has been a brilliant scientific advisor for many ISPAD members, a great educator to all those involved in diabetes care and an outstanding advocate for all issues concerning children with diabetes. He served on the first ISGD Advisory Council from 1976 – 1980, and was the second president of ISGD for two terms from 1981-1984-1987. Graduates of the Pittsburgh program headed by Allan Drash for more than a quarter century populate an astounding number of academic positions and especially division chief positions, and include many distinguished members of ISPAD. In 2006 he was awarded our highest honour, the ISPAD Prize of Achievement.
He will be remembered to those upcoming ISPAD generations not only for his numerous achievements but also through the ISPAD Allan Drash Fellowship. Starting in 2006, ISPAD has been awarding an annual 6 week clinical fellowship for applicants below 45 years in his name. ISPAD Position Statement on Glargine and Cancer Risk
ISPAD supports statements of other societies such as the American Diabetes Association ADA, LWPES, FDA and European Medicines Agency EMEA that on the basis of the currently available data, a relationship between insulin glargine and cancer cannot be confirmed nor excluded, and the concerns require further in-depth evaluation.
ISPAD does not recommend that patients receiving insulin glargine should be switched to an alternative basal insulin. Also, with the current knowledge and the proven benefits of the drug particularly regarding the lower rate of hypoglycemia compared to human insulin, no reason for a recommendation not to start pediatric patients on glargine is warranted. Therapeutic alternatives may be considered in type 2 diabetic patients with preexisting cancer or an increased familial breast cancer risk. Patients and parents should be made aware that the link between insulin and cancer has been suggested but not proven, and only in adults with type 2 diabetes mellitus. ISPAD supports further research into the long-term safety of all the insulin analogs. The full statement can be downloaded below. Access to Essential Diabetes Medicines for Children in the Developing World
This meeting in London Oct 25th was initiated by IDF/Life for a Child (www.lifeforachild.org) and hosted by Diabetes UK. A large number organizations and companies were represented. The aims were two-fold:
1. To find urgent but "temporary" humanitarian strategies to keep children with type 1 diabetes in developing countries alive. 2. To set the stage for longterm structural review of access to essential drugs and glucose monitoring supplies for all people with diabetes in developing countries. The outcome was a huge success with pledges from the industry for supplying 5,500 children with insulin next year and 29,000 by 2015 and providing 1 million syringes. ISPAD pledged structural support and assistance in the training of pediatricians and healthcare professionals in childhood and adolescent diabetes through its membership network.
Download: Results_IDF_Access_Meeting.PDF
|